293 related articles for article (PubMed ID: 18938074)
21. Influence of human serum albumin on longitudinal and transverse relaxation rates (r1 and r2) of magnetic resonance contrast agents.
Giesel FL; von Tengg-Kobligk H; Wilkinson ID; Siegler P; von der Lieth CW; Frank M; Lodemann KP; Essig M
Invest Radiol; 2006 Mar; 41(3):222-8. PubMed ID: 16481904
[TBL] [Abstract][Full Text] [Related]
22. Gd-complexes of DTPA-bis(amide) conjugates of tranexamic acid and its esters with high relaxivity and stability for magnetic resonance imaging.
Dutta S; Park JA; Jung JC; Chang Y; Kim TJ
Dalton Trans; 2008 Apr; (16):2199-206. PubMed ID: 18398546
[TBL] [Abstract][Full Text] [Related]
23. Relaxivity of Gadopentetate Dimeglumine (Magnevist), Gadobutrol (Gadovist), and Gadobenate Dimeglumine (MultiHance) in human blood plasma at 0.2, 1.5, and 3 Tesla.
Pintaske J; Martirosian P; Graf H; Erb G; Lodemann KP; Claussen CD; Schick F
Invest Radiol; 2006 Mar; 41(3):213-21. PubMed ID: 16481903
[TBL] [Abstract][Full Text] [Related]
24. A novel cholic acid-based contrast enhancement agent for targeted MRI.
Chong HS; Song HA; Lim S; Macrenaris K; Ma X; Lee H; Bui P; Meade T
Bioorg Med Chem Lett; 2008 Apr; 18(7):2505-8. PubMed ID: 18337094
[TBL] [Abstract][Full Text] [Related]
25. Accumulation of MRI contrast agents in malignant fibrous histiocytoma for gadolinium neutron capture therapy.
Fujimoto T; Ichikawa H; Akisue T; Fujita I; Kishimoto K; Hara H; Imabori M; Kawamitsu H; Sharma P; Brown SC; Moudgil BM; Fujii M; Yamamoto T; Kurosaka M; Fukumori Y
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S355-8. PubMed ID: 19386506
[TBL] [Abstract][Full Text] [Related]
26. Hydrothermally synthesized PEGylated calcium phosphate nanoparticles incorporating Gd-DTPA for contrast enhanced MRI diagnosis of solid tumors.
Mi P; Kokuryo D; Cabral H; Kumagai M; Nomoto T; Aoki I; Terada Y; Kishimura A; Nishiyama N; Kataoka K
J Control Release; 2014 Jan; 174():63-71. PubMed ID: 24211705
[TBL] [Abstract][Full Text] [Related]
27. Novel gadolinium(III) polyaminocarboxylate macrocyclic complexes as potential magnetic resonance imaging contrast agents.
Chan KW; Barra S; Botta M; Wong WT
J Inorg Biochem; 2004 May; 98(5):677-82. PubMed ID: 15134912
[TBL] [Abstract][Full Text] [Related]
28. Dynamic contrast enhanced MRI of mouse fibrosarcoma using small-molecular and novel macromolecular contrast agents.
Ivanusa T; Beravs K; Medic J; Sersa I; Sersa G; Jevtic V; Demsar F; Mikac U
Phys Med; 2007 Dec; 23(3-4):85-90. PubMed ID: 18061121
[TBL] [Abstract][Full Text] [Related]
29. A Gd3+-based magnetic resonance imaging contrast agent sensitive to beta-galactosidase activity utilizing a receptor-induced magnetization enhancement (RIME) phenomenon.
Hanaoka K; Kikuchi K; Terai T; Komatsu T; Nagano T
Chemistry; 2008; 14(3):987-95. PubMed ID: 17992679
[TBL] [Abstract][Full Text] [Related]
30. Magnetic resonance imaging of contrast-enhanced polyelectrolyte complexes.
Huang M; Huang ZL; Bilgen M; Berkland C
Nanomedicine; 2008 Mar; 4(1):30-40. PubMed ID: 18201943
[TBL] [Abstract][Full Text] [Related]
31. Gadolinium chelate coated gold nanoparticles as contrast agents for both X-ray computed tomography and magnetic resonance imaging.
Alric C; Taleb J; Le Duc G; Mandon C; Billotey C; Le Meur-Herland A; Brochard T; Vocanson F; Janier M; Perriat P; Roux S; Tillement O
J Am Chem Soc; 2008 May; 130(18):5908-15. PubMed ID: 18407638
[TBL] [Abstract][Full Text] [Related]
32. High relaxivities and strong vascular signal enhancement for NaGdF4 nanoparticles designed for dual MR/optical imaging.
Naccache R; Chevallier P; Lagueux J; Gossuin Y; Laurent S; Vander Elst L; Chilian C; Capobianco JA; Fortin MA
Adv Healthc Mater; 2013 Nov; 2(11):1478-88. PubMed ID: 23666643
[TBL] [Abstract][Full Text] [Related]
33. Thermodynamic stability and kinetic inertness of a Gd-DTPA bisamide complex grafted onto gold nanoparticles.
Mogilireddy V; Déchamps-Olivier I; Alric C; Laurent G; Laurent S; Vander Elst L; Muller R; Bazzi R; Roux S; Tillement O; Chuburu F
Contrast Media Mol Imaging; 2015; 10(3):179-87. PubMed ID: 25130910
[TBL] [Abstract][Full Text] [Related]
34. Gold nanoparticles functionalised with stable, fast water exchanging Gd3+ chelates as high relaxivity contrast agents for MRI.
Ferreira MF; Mousavi B; Ferreira PM; Martins CI; Helm L; Martins JA; Geraldes CF
Dalton Trans; 2012 May; 41(18):5472-5. PubMed ID: 22467054
[TBL] [Abstract][Full Text] [Related]
35. Cyclodextrin-based bimodal fluorescence/MRI contrast agents: an efficient approach to cellular imaging.
Kotková Z; Kotek J; Jirák D; Jendelová P; Herynek V; Berková Z; Hermann P; Lukes I
Chemistry; 2010 Sep; 16(33):10094-102. PubMed ID: 20583046
[TBL] [Abstract][Full Text] [Related]
36. Investigation using an HER-2/neu transgenic mouse model of a newly developed MR contrast agent with the effect of an antitumor drug.
Sonoda A; Nitta N; Ohta S; Nitta-Seko A; Murata S; Jo J; Tabata Y; Takahashi M; Tani T; Murata K
J Magn Reson Imaging; 2009 Oct; 30(4):907-10. PubMed ID: 19787744
[TBL] [Abstract][Full Text] [Related]
37. Strategies for increasing relaxivity of gold nanoparticle based MRI contrast agents.
Warsi MF; Chechik V
Phys Chem Chem Phys; 2011 May; 13(20):9812-7. PubMed ID: 21503280
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and characterization of novel natural product-Gd(III) MRI contrast agent conjugates.
Efthimiadou EK; Katsarou ME; Fardis M; Zikos C; Pitsinos EN; Kazantzis A; Leondiadis L; Sagnou M; Vourloumis D
Bioorg Med Chem Lett; 2008 Dec; 18(23):6058-61. PubMed ID: 18938075
[TBL] [Abstract][Full Text] [Related]
39. In vivo MR detection of vascular endothelial injury using a new class of MRI contrast agent.
Yamamoto T; Ikuta K; Oi K; Abe K; Uwatoku T; Hyodo F; Murata M; Shigetani N; Yoshimitsu K; Shimokawa H; Utsumi H; Katayama Y
Bioorg Med Chem Lett; 2004 Jun; 14(11):2787-90. PubMed ID: 15125933
[TBL] [Abstract][Full Text] [Related]
40. Flow-injection EPR investigation on OH radical scavenging activity of Gd(III) containing MRI contrast media.
Mori Y; Watanabe R; Sakamoto S; Endo N; Nakano S; Kanaori K; Takashima H; Ohkawa M; Tajima K
J Med; 2004; 35(1-6):49-61. PubMed ID: 18084864
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
